Overview

A Study to Evaluate the Effect of an Acidic Formulation of Acalabrutinib (ACP-196), Acidic Beverage, or Grapefruit Juice on the Pharmacokinetics (PK) of ACP-196 Alone and Coadministered With Omeprazole

Status:
Completed

Trial end date:
2016-03-15

Target enrollment:

Participant gender:

Summary

This study will evaluate the effect of an acidic formulation of Acalabrutinib (ACP-196), acidic beverage, or grapefruit Juice on the PK of ACP-196 alone and coadministered with omeprazole.

Phase:

Phase 1

Details

Lead Sponsor:

Acerta Pharma BV

Treatments:

Acalabrutinib
Omeprazole